Moleculin Biotech Inc. (MBRX) at a glance

Moleculin Biotech Inc. (MBRX) is a Healthcare company. It trades at $2.73. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (15/100).

Price
$2.73
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.79 to $24.00
Vestovix Score47/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
15